1h Free Analyst Time
The human chorionic gonadotropin (HCG) market is poised to grow by $303.49 mn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. The report on the human chorionic gonadotropin (HCG) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the prevalence of infertility, rising demand for IVF, and rising clinical application.
The human chorionic gonadotropin (HCG) market analysis includes technology segment and geographic landscape.
The human chorionic gonadotropin (HCG) market is segmented as below:
By Technology
- Natural source extraction
- Recombinant technology
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the human chorionic gonadotropin (HCG) market covers the following areas:
- Human chorionic gonadotropin (HCG) market sizing
- Human chorionic gonadotropin (HCG) market forecast
- Human chorionic gonadotropin (HCG) market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Technology
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global human chorionic gonadotropin (HCG) market: Biocare Medical LLC, Cigna Corp., Cipla Ltd., Ferring B.V., Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Kamia Biomedical Company, Lee BioSolutions Inc, Lupin Ltd., Merck and Co. Inc., MyBioSource Inc., Prospec Tany Technogene Ltd., Sanzyme P Ltd., Scripps Laboratories Inc., and Sun Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the emerging trend of delayed pregnancies among women.`
According to the report, one of the major drivers for this market is the increase in the prevalence of infertility.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biocare Medical LLC
- Cigna Corp.
- Cipla Ltd.
- Ferring B.V.
- Fresenius Kabi AG
- Intas Pharmaceuticals Ltd.
- Kamia Biomedical Company
- Lee BioSolutions Inc
- Lupin Ltd.
- Merck and Co. Inc.
- MyBioSource Inc.
- Prospec Tany Technogene Ltd.
- Sanzyme P Ltd.
- Scripps Laboratories Inc.
- Sun Pharmaceutical Industries Ltd.
